Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Dyslipidemia

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 37 articles: HTML format Text format

Single Articles

February 2018
1. GUPTA R, Singh Y
   Treatment gaps in severe hypercholesterolemia.
   Int J Cardiol. 2018;252:199-200.
   PubMed     Text format    
   
   
   November 2017
2. LIN XL, Liu MH
   Statin and ezetimibe combination therapy: New therapeutic options for lowering Low-Density Lipoprotein Cholesterol.
   Int J Cardiol. 2017;247:49.
   PubMed     Text format    
   
   
   March 2017
3. LEE H, Choi EK, Lee SH, Han KD, et al
   Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study.
   Int J Cardiol. 2017 Mar 28. pii: S0167-5273(16)32706.
   PubMed     Text format     Abstract available
   
   
   February 2017
4. DUFOUR R, Bergeron J, Gaudet D, Weiss R, et al
   Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment.
   Int J Cardiol. 2017;228:754-760.
   PubMed     Text format     Abstract available
   
   
   January 2017
5. LIN PY, Lee FY, Wallace CG, Chen KH, et al
   The therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced rabbit aortic atherosclerosis and stiffness.
   Int J Cardiol. 2017;227:938-949.
   PubMed     Text format     Abstract available
   
   
   
6. HU D, Yang Y, Peng DQ
   Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in statin-naive patients with coronary artery disease.
   Int J Cardiol. 2017;227:61-65.
   PubMed     Text format     Abstract available
   
   
   
7. KISHIMOTO S, Kajikawa M, Maruhashi T, Iwamoto Y, et al
   Endothelial dysfunction and abnormal vascular structure are simultaneously present in patients with heart failure with preserved ejection fraction.
   Int J Cardiol. 2017 Jan 5. pii: S0167-5273(16)32405.
   PubMed     Text format     Abstract available
   
   
   November 2016
8. KUWABARA M, Niwa K, Nishihara S, Nishi Y, et al
   Hyperuricemia is an independent competing risk factor for atrial fibrillation.
   Int J Cardiol. 2016 Nov 15. pii: S0167-5273(16)32841.
   PubMed     Text format     Abstract available
   
   
   August 2016
9. BAEK YS, Yang PS, Kim TH, Uhm JS, et al
   Delayed recurrence of atrial fibrillation 2years after catheter ablation is associated with metabolic syndrome.
   Int J Cardiol. 2016;223:276-281.
   PubMed     Text format     Abstract available
   
   
   
10. REYES EB, Ha JW, Firdaus I, Ghazi AM, et al
    Heart failure across Asia: Same healthcare burden but differences in organization of care.
    Int J Cardiol. 2016;223:163-167.
    PubMed     Text format     Abstract available
    
    
    July 2016
11. MENDEZ-BAILON M, Munoz-Rivas N, Jimenez-Garcia R, Esteban-Hernandez J, et al
    Impact of type 2 diabetes mellitus in hospitalizations for atrial fibrillation in Spain (2004-2013).
    Int J Cardiol. 2016;221:688-694.
    PubMed     Text format     Abstract available
    
    
    June 2016
12. SAHINER L, Asil S, Kaya EB, Ozer N, et al
    Percutaneous Implantation of the self-expanding valve Prosthesis a patient with homozygous familial hypercholesterolemia severe aortic stenosis and porcelain aorta.
    Int J Cardiol. 2016;220:661-664.
    PubMed     Text format     Abstract available
    
    
    
13. XIA SJ, Du X, Li C, Wu JH, et al
    Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
    Int J Cardiol. 2016;220:284-289.
    PubMed     Text format     Abstract available
    
    
    
14. WU AH, Gladden JD, Ahmed M, Ahmed A, et al
    Relation of serum uric acid to cardiovascular disease.
    Int J Cardiol. 2016;213:4-7.
    PubMed     Text format     Abstract available
    
    
    May 2016
15. PLAKHT Y, Gilutz H, Shiyovich A
    Decreased admission serum albumin level is an independent predictor of long-term mortality in hospital survivors of acute myocardial infarction. Soroka Acute Myocardial Infarction II (SAMI-II) project.
    Int J Cardiol. 2016;219:20-24.
    PubMed     Text format     Abstract available
    
    
    April 2016
16. DI MINNO MN, Di Minno A, Ambrosino P, Songia P, et al
    Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosis.
    Int J Cardiol. 2016;217:1-6.
    PubMed     Text format     Abstract available
    
    
    March 2016
17. MASCITELLI L, Goldstein MR
    Might ezetimibe be considered an expensive placebo?
    Int J Cardiol. 2016;207:48-9.
    PubMed     Text format    
    
    
    January 2016
18. FUENTES F, Alcala-Diaz JF, Watts GF, Mata P, et al
    Diabetes, statins and FH.
    Int J Cardiol. 2016;203:575.
    PubMed     Text format    
    
    
    
19. NAKOU ES, Simantirakis EN, Kallergis EM, Skalidis EI, et al
    Long-standing sinus arrest due to the occlusion of sinus node artery during percutaneous coronary intervention: Clinical implications and management.
    Int J Cardiol. 2016;203:432-3.
    PubMed     Text format    
    
    
    
20. TANG L, Jiang L, Pan XD, Chen PP, et al
    Extremely severe aortic stenosis developed in a young female patient with underdiagnosis of homozygous familial hypercholesterolemia: An 8-year follow-up.
    Int J Cardiol. 2016;207:372-374.
    PubMed     Text format    
    
    
    
21. FILIPPATOS TD, Elisaf MS
    Effects of ezetimibe/simvastatin combination on metabolic parameters.
    Int J Cardiol. 2016;202:273-4.
    PubMed     Text format    
    
    
    
22. KOH KK, Oh PC, Sakuma I
    Reply to comment on: Effects of ezetimibe/simvastatin combination on metabolic parameters by Prof. Moses S Elisaf.
    Int J Cardiol. 2016;202:154-5.
    PubMed     Text format    
    
    
    
23. YU Q, Su X, Liu E
    Could familial hypercholesterolemia oppose the diabetogenic effect of statin? Comments on a new SAFEHEART study.
    Int J Cardiol. 2016;202:954-5.
    PubMed     Text format    
    
    
    
24. ZU L, Ren C, Pan B, Zhou B, et al
    Endothelial microparticles after antihypertensive and lipid-lowering therapy inhibit the adhesion of monocytes to endothelial cells.
    Int J Cardiol. 2016;202:756-9.
    PubMed     Text format    
    
    
    
25. OIKONOMOU E, Siasos G, Tousoulis D
    Atherogenesis and hyperlipidemia a not straightforward association: We really need a novel biomarker?
    Int J Cardiol. 2016;202:586-8.
    PubMed     Text format    
    
    
    April 2015
26. WATTS GF, Shaw JE, Pang J, Magliano DJ, et al
    Prevalence and treatment of familial hypercholesterolaemia in Australian communities.
    Int J Cardiol. 2015;185:69-71.
    PubMed     Text format    
    
    
    
27. MACHADO VA, Fonseca FA, Fonseca HA, Malina DT, et al
    Plant sterol supplementation on top of lipid-lowering therapies in familial hypercholesterolemia.
    Int J Cardiol. 2015;184:570-2.
    PubMed     Text format    
    
    
    March 2015
28. TOURNADRE A, Tatar Z, Pereira B, Chevreau M, et al
    Application of the European Society of Cardiology, Adult Treatment Panel III and American College of Cardiology/American Heart Association guidelines for cardiovascular risk management in a French cohort of rheumatoid arthritis.
    Int J Cardiol. 2015;183:149-54.
    PubMed     Text format     Abstract available
    
    
    
29. RUBINSTEIN AL, Irazola VE, Calandrelli M, Elorriaga N, et al
    Multiple cardiometabolic risk factors in the Southern Cone of Latin America: a population-based study in Argentina, Chile, and Uruguay.
    Int J Cardiol. 2015;183:82-8.
    PubMed     Text format     Abstract available
    
    
    
30. WEI Y, Guo H, The E, Che W, et al
    Persistent lipid abnormalities in statin-treated coronary artery disease patients with and without diabetes in China.
    Int J Cardiol. 2015;182:469-75.
    PubMed     Text format     Abstract available
    
    
    February 2015
31. CHEN CX, Hay JW
    Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
    Int J Cardiol. 2015;181:417-24.
    PubMed     Text format     Abstract available
    
    
    January 2015
32. SHIH CH, Ou SY, Shih CJ, Chen YT, et al
    Bidirectional association between the risk of comorbidities and the diagnosis of retinal vein occlusion in an elderly population: a nationwide population-based study.
    Int J Cardiol. 2015;178:256-61.
    PubMed     Text format     Abstract available
    
    
    
33. DE GONZALO-CALVO D, Llorente-Cortes V, Orbe J, Paramo JA, et al
    High triglyceride-low HDL cholesterol lipid profile is associated with a dysregulated gene expression in mononuclear leukocyte from hypercholesterolemic patients.
    Int J Cardiol. 2015;178:102-4.
    PubMed     Text format    
    
    
    
34. HERMANNS MI, Grossmann V, Spronk HM, Schulz A, et al
    Distribution, genetic and cardiovascular determinants of FVIII:c - Data from the population-based Gutenberg Health Study.
    Int J Cardiol. 2015;187:166-74.
    PubMed     Text format     Abstract available
    
    
    
35. KRINTUS M, Kozinski M, Boudry P, Lackner K, et al
    Defining normality in a European multinational cohort: Critical factors influencing the 99th percentile upper reference limit for high sensitivity cardiac troponin I.
    Int J Cardiol. 2015;187:256-63.
    PubMed     Text format     Abstract available
    
    
    September 2014
36. ROTH EM, Taskinen MR, Ginsberg HN, Kastelein JJ, et al
    Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: results of a 24 week, double-blind, randomized Phase 3 trial.
    Int J Cardiol. 2014;176:55-61.
    PubMed     Text format     Abstract available
    
    
    July 2014
37. ZHAO X, Bu L, Qin S, Kong D, et al
    Early development of xanthoma and coronary disease in a young female with homozygous familial hypercholesterolemia.
    Int J Cardiol. 2014 Jul 6. pii: S0167-5273(14)01170.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: